Death domain-containing adaptor protein, Apoptosis signaling molecule, Receptor-associated signaling adaptor, Nuclear factor-interacting adaptor, Other (not classified as receptor, enzyme, transporter, transcription factor, ion channel, or histone modifier)
01
Overview
FAS-associated death domain protein (FADD) is a 23 kDa adaptor protein consisting of two main domains: a C-terminal death domain and an N-terminal death effector domain. It functions by bridging death receptors such as Fas (CD95) with initiator caspases (notably procaspase-8 and -10), forming the death-inducing signaling complex (DISC) that triggers apoptosis. FADD also regulates necroptosis, autophagic cell death, cell proliferation, and immune system responses. It is encoded by the FADD gene on chromosome 11q13.3, and its expression and function are crucial for proper cell death signaling, immune homeostasis, and genome surveillance. Dysregulation or mutation of FADD is implicated in cancer, autoimmunity, and infectious diseases.
Other names
MORT1Fas-associated protein with death domainFADD
02
Mechanism of action
Promote or inhibit death receptor signaling, leading to apoptosis. Induction of cell cycle arrest. Potential inhibition of FADD for drug-resistant cancer therapy (proposed, not established clinically).
03
Biological functions
Apoptosis (programmed cell death) via death-inducing signaling complex (DISC)Necroptosis regulationAutophagic cell death modulationCell cycle regulationCell proliferationImmune response (T and B cell homeostasis, TLR signaling)DNA damage response and genome surveillance
04
Disease associations
Cancer, including tumor surveillance and the effect of FADD mutations in malignanciesAutoimmune disease (defects associated with lymphoproliferation and autoantibody production)Inflammation (immune modulation)Infection (roles in immune system signaling and apoptosis)Neurodegenerative processes, indirectly through apoptosisCardiovascular disease (not reported prominently in primary sources)Other (embryonic development, hematopoietic abnormalities)
05
Safety considerations
Inhibition or mutation of FADD can result in severe autoimmune complications, lymphadenopathy, and splenomegalyPotential embryonic lethality if FADD function is disruptedRisk of impaired immune response or unchecked proliferation of lymphoid cellsFADD-targeting therapies may cause excessive apoptosis or necroptosis, leading to tissue damage
06
Interacting drugs
Paclitaxel (Taxol), reported to interfere with FADD-related cell cycle pathways and proposed as a drug in ovarian cancer
3 more in the full profile.
07
Biomarkers
FADD expression and post-translational modifications (e.g., phosphorylation at Ser-194) are used as biomarkers to monitor apoptosis and immune cell activityFADD mutations in malignancies can inform cancer prognosis and response to therapyFADD presence and localization may indicate propensity for cell death or cell survival in disease tissues
Beyond the preview
Go deeper on FAS-associated death domain protein (FADD).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on FAS-associated death domain protein (FADD).